FDA PDUFA goal date of August 15, 2025, for TNX-102 SL for the management of fibromyalgia; if approved, TNX-102 SL would become the first new drug for treating fibromyalgia in more than 15 years Annou ...

We are delighted to have been awarded a £9 million Wellcome grant to develop a new Discovery Research Platform for Medical Humanities (DRP-MH). The Platform will create space for experimentation and ...